Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-10-18

Clinical Trial Update: Sayana Press UK Self-Injection Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial updating Sayana Press self-injection in the UK for contraception has completed, with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sayana Press (medroxyprogesterone acetate)

Snippet

Sponsor: Pfizer | Conditions: Contraception | Phase 4 | Status: COMPLETED | Results posted: 2019-10-18